We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+26.25%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$925M
AUM Growth
+$33.9M
Cap. Flow
-$117M
Cap. Flow %
-12.67%
Top 10 Hldgs %
56.49%
Holding
80
New
21
Increased
13
Reduced
13
Closed
24

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.4M
2
XLRN
Acceleron Pharma
XLRN
+$26.9M
3
PRPL icon
Purple Innovation
PRPL
+$19.6M
4
SPLK
Splunk Inc
SPLK
+$15.8M
5
NOMD icon
Nomad Foods
NOMD
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 25.01%
2 Consumer Discretionary 12.8%
3 Communication Services 9.57%
4 Industrials 8.63%
5 Technology 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRI icon
26
Stoneridge
SRI
$213M
$10.5M 1.14%
348,301
-53,100
-13% -$1.38M
MIME
27
DELISTED
Mimecast Limited
MIME
$9.89M 1.07%
173,924
-150,400
-46% -$6.95M
TENB icon
28
Tenable Holdings
TENB
$4.01B
$9.67M 1.05%
185,000
-49,350
-21% -$1.96M
TVRD
29
Tvardi Therapeutics
TVRD
$23.4M
$9.48M 1.03%
17,405
TWLO icon
30
Twilio
TWLO
$36.6B
$8.72M 0.94%
25,753
+4,979
+24% +$1.56M
BFT
31
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
$8.69M 0.94%
+575,450
New +$6.56M
SLGL icon
32
Sol-Gel Technologies
SLGL
$288M
$8.15M 0.88%
83,280
TWLO icon
33
PUT
Twilio
TWLO
$36.6B
$7.48M 0.81%
+22,100
New +$6.91M
MTEM
34
DELISTED
Molecular Templates, Inc.
MTEM
$7.15M 0.77%
50,766
+18,930
+59% +$2.8M
WNS
35
DELISTED
WNS Holdings
WNS
$6.76M 0.73%
93,834
+38,834
+71% +$2.6M
GTYH
36
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$6.01M 0.65%
1,159,600
WDAY icon
37
PUT
Workday
WDAY
$44.4B
$5.99M 0.65%
+25,000
New +$5.62M
STEM icon
38
Stem
STEM
$52.7M
$5.85M 0.63%
+14,300
New +$3.6M
DIS icon
39
PUT
Walt Disney
DIS
$181B
$5.54M 0.6%
+30,600
New +$4.39M
GOOS
40
Canada Goose Holdings
GOOS
$856M
$5.41M 0.59%
+181,700
New +$6.06M
FOUR icon
41
Shift4
FOUR
$3.26B
$5.28M 0.57%
+70,000
New +$4.19M
RAPT
42
DELISTED
RAPT Therapeutics
RAPT
$5.01M 0.54%
+31,701
New +$6.89M
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.77M 0.52%
1,972,056
+1,260,504
+177% +$2.87M
SCYX icon
44
SCYNEXIS
SCYX
$52M
$4.49M 0.49%
73,381
+40,000
+120% +$1.87M
TENB icon
45
PUT
Tenable Holdings
TENB
$4.01B
$3.83M 0.41%
+73,200
New +$2.9M
GEG icon
46
Great Elm Group
GEG
$69.3M
$3.63M 0.39%
1,259,049
TMQ
47
Trilogy Metals
TMQ
$656M
$3.35M 0.36%
1,673,461
+150,000
+10% +$266K
WORK
48
DELISTED
Slack Technologies, Inc.
WORK
$3.17M 0.34%
+75,000
New +$2.53M
AUPH icon
49
CALL
Aurinia Pharmaceuticals
AUPH
$2.11B
$2.77M 0.3%
200,000
XAIR icon
50
Beyond Air
XAIR
$3.86M
$2.69M 0.29%
1,278

Similar funds

Kingdon Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Kingdon Capital Management held 80 positions worth $925M, up 3.8% from $891M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Kingdon Capital Management withdrew a net $117M in Q4 2020, closing 24 positions and reducing 13 holdings. Its most notable exit was Merck, an estimated $28.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Kingdon Capital Management opened a new position in Baidu worth $22.9M.

  • Kingdon Capital Management's largest Q4 2020 buy was Baidu: 105,815 shares worth $22.9M.
  • Kingdon Capital Management added most to Lithia Motors in Q4 2020, an estimated $7.62M increase.
  • Kingdon Capital Management's biggest Q4 2020 reduction was Acceleron Pharma, cutting an estimated $26.9M.
  • Kingdon Capital Management fully exited Merck in Q4 2020, selling an estimated $28.4M.
  • Kingdon Capital Management's ten largest holdings make up 56% of its $925M portfolio in Q4 2020.
  • Kingdon Capital Management opened 21 new positions and closed 24 in Q4 2020.
  • Kingdon Capital Management's portfolio value rose 3.8% quarter-over-quarter to $925M.

Based on Kingdon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.